D.E. Shaw & Co
DMK

D.E. Shaw & Co’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

D.E. Shaw & Co’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-152
Closed -$34K – 4048
2018
Q2 		$34K Buy
+152
New +$40.7K ﹤0.01% 3659

Other funds holding DMK

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

D.E. Shaw & Co's DMK Position: Q3 2018 in Review

D.E. Shaw & Co sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2018, closing a stake of 152 shares — an estimated $34K sold.

D.E. Shaw & Co first reported a position in DMK in Q2 2018 and held it in 1 quarter. The position peaked at $34K in Q2 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q3 2018.

  • D.E. Shaw & Co reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 152 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2018, an estimated $34K.
  • D.E. Shaw & Co first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2018 and held it in 1 quarter.
  • D.E. Shaw & Co's DMK Pharmaceuticals Corporation Common Stock position peaked at $34K in Q2 2018.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.